How effective is Metoprolol Tartrate for Paroxysmal Supraventricular Tachycardia? (a real world drug study)

Summary:

Overall ratings: 3.4/5
Long term ratings: 3.6/5

This is a phase IV clinical study of how effective Metoprolol tartrate (metoprolol tartrate) is for Paroxysmal supraventricular tachycardia and for what kind of people. The study is created by eHealthMe from 48 Metoprolol tartrate users and is updated continuously.

What is Metoprolol tartrate?

Metoprolol tartrate has active ingredients of metoprolol tartrate. It is often used in high blood pressure. eHealthMe is studying from 89,747 Metoprolol tartrate users. Check the latest studies of Metoprolol tartrate.

What is Paroxysmal supraventricular tachycardia?

Paroxysmal supraventricular tachycardia is found to be associated with 1,092 drugs and 1,872 conditions by eHealthMe. Check the latest studies of Paroxysmal supraventricular tachycardia.


On Jul, 09, 2026

48 people are studied for taking Metoprolol tartrate in Paroxysmal supraventricular tachycardia

Overall effectiveness (number of people):

Does Metoprolol tartrate work for your Paroxysmal supraventricular tachycardia (overall)?

Long term (1+ years) effectiveness (number of people):

Does Metoprolol tartrate work for your Paroxysmal supraventricular tachycardia (long term)?

Metoprolol tartrate effectiveness for Paroxysmal supraventricular tachycardia (number of people):

Overall:
  • not at all: 1
  • somewhat: 8
  • moderate: 17
  • high: 15
  • very high: 7
Long Term:
  • not at all: 0
  • somewhat: 4
  • moderate: 10
  • high: 13
  • very high: 5

Gender of people who take Metoprolol tartrate for Paroxysmal supraventricular tachycardia *:

  • female: 85.42 %
  • male: 14.58 %

Age of people who take Metoprolol tartrate for Paroxysmal supraventricular tachycardia *:

  • 0-1: 2.08 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 14.58 %
  • 30-39: 16.67 %
  • 40-49: 25.0 %
  • 50-59: 14.58 %
  • 60+: 27.08 %

Who find Metoprolol Tartrate more effective for Paroxysmal Supraventricular Tachycardia?

Gender of people who take Metoprolol tartrate for Paroxysmal supraventricular tachycardia *:

  • female: 95.45 %
  • male: 4.55 %

Age of people who take Metoprolol tartrate for Paroxysmal supraventricular tachycardia *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 9.09 %
  • 30-39: 18.18 %
  • 40-49: 27.27 %
  • 50-59: 13.64 %
  • 60+: 31.82 %

* Approximation only. Some reports may have incomplete information.

Do you take Metoprolol tartrate?

- You can start a phase IV clinical trial to monitor Metoprolol tartrate safety and effectiveness.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Alternative drugs to, pros and cons of:

Treatments, associated drugs and conditions:

How the study uses the data?

The study is based on metoprolol tartrate (the active ingredients of Metoprolol tartrate) and Metoprolol tartrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: